Cubist Systematic Strategies’s CytomX Therapeutics CTMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-98,383
| Closed | -$101K | – | 1620 |
|
|
2024
Q4 | $101K | Buy |
98,383
+73,923
| +302% | +$76.1K | ﹤0.01% | 1273 |
|
|
2024
Q3 | $28.9K | Sell |
24,460
-57,594
| -70% | -$68K | ﹤0.01% | 1303 |
|
|
2024
Q2 | $100K | Buy |
82,054
+40,309
| +97% | +$49.2K | ﹤0.01% | 1174 |
|
|
2024
Q1 | $91K | Buy |
+41,745
| New | +$91K | ﹤0.01% | 1834 |
|
|
2022
Q3 | – | Sell |
-9,346
| Closed | -$17K | – | 3655 |
|
|
2022
Q2 | $17K | Hold |
9,346
| – | – | ﹤0.01% | 3692 |
|
|
2022
Q1 | $25K | Hold |
9,346
| – | – | ﹤0.01% | 3438 |
|
|
2021
Q4 | $40K | Hold |
9,346
| – | – | ﹤0.01% | 3330 |
|
|
2021
Q3 | $48K | Sell |
9,346
-160
| -2% | -$822 | ﹤0.01% | 2839 |
|
|
2021
Q2 | $60K | Hold |
9,506
| – | – | ﹤0.01% | 2771 |
|
|
2021
Q1 | $73K | Sell |
9,506
-28,341
| -75% | -$218K | ﹤0.01% | 2693 |
|
|
2020
Q4 | $248K | Buy |
37,847
+13,803
| +57% | +$90.4K | ﹤0.01% | 2128 |
|
|
2020
Q3 | $160K | Buy |
24,044
+17,759
| +283% | +$118K | ﹤0.01% | 2191 |
|
|
2020
Q2 | $52K | Sell |
6,285
-7,371
| -54% | -$61K | ﹤0.01% | 2268 |
|
|
2020
Q1 | $105K | Buy |
13,656
+7
| +0.1% | +$54 | ﹤0.01% | 1899 |
|
|
2019
Q4 | $113K | Buy |
+13,649
| New | +$113K | ﹤0.01% | 2169 |
|
|
2019
Q3 | – | Sell |
-46,779
| Closed | -$525K | – | 2254 |
|
|
2019
Q2 | $525K | Buy |
46,779
+31,601
| +208% | +$355K | 0.01% | 1447 |
|
|
2019
Q1 | $163K | Sell |
15,178
-23,768
| -61% | -$255K | 0.01% | 1871 |
|
|
2018
Q4 | $588K | Buy |
38,946
+14,023
| +56% | +$212K | 0.03% | 859 |
|
|
2018
Q3 | $461K | Buy |
24,923
+16,598
| +199% | +$307K | 0.03% | 872 |
|
|
2018
Q2 | $190K | Sell |
8,325
-12,754
| -61% | -$291K | 0.01% | 1372 |
|
|
2018
Q1 | $600K | Sell |
21,079
-5,648
| -21% | -$161K | 0.04% | 700 |
|
|
2017
Q4 | $564K | Buy |
+26,727
| New | +$564K | 0.03% | 821 |
|
|
2017
Q3 | – | Sell |
-11,235
| Closed | -$174K | – | 1865 |
|
|
2017
Q2 | $174K | Buy |
+11,235
| New | +$174K | 0.01% | 1336 |
|